Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Ajanta Pharma Ltd

Healthcare | Mid Cap

Ajanta Pharma Ltd Health Insights
Health Score : 7.72Health Score : 7.72

Ajanta Pharma shows a very strong financial profile, marked by exceptional profitability, impressive growth, and an almost debt-free status. The company is very effective at turning sales into profit and is expanding its business and earnings at a rapid rate. This low-debt approach makes it a very stable and low-risk company from a long-term perspective. However, a key area of concern is its operational efficiency. The company takes a long time to sell its products and collect payments from customers, and it does not generate as much revenue as it could from its assets. While it pays dividends, the coverage for these has been thin recently. The future outlook appears positive due to strong growth and profitability, but its success will also depend on how well it manages its day-to-day operations.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Ajanta Pharma Ltd Health Insights
Health Score : 7.72Health Score : 7.72

Ajanta Pharma shows a very strong financial profile, marked by exceptional profitability, impressive growth, and an almost debt-free status. The company is very effective at turning sales into profit and is expanding its business and earnings at a rapid rate. This low-debt approach makes it a very stable and low-risk company from a long-term perspective. However, a key area of concern is its operational efficiency. The company takes a long time to sell its products and collect payments from customers, and it does not generate as much revenue as it could from its assets. While it pays dividends, the coverage for these has been thin recently. The future outlook appears positive due to strong growth and profitability, but its success will also depend on how well it manages its day-to-day operations.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

40.45

Overvalued

Industry Median

28.62

Overvalued
Neutral

Mid Cap Median

36.34

Neutral

P/E RATIO

36.27

P/B RATIO

8.47

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Neutral

Mid Cap Median

7.64

Neutral

P/S RATIO

6.95

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Neutral

Mid Cap Median

6.30

Neutral

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

24.16

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹3065.2 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is experiencing a period of outstanding growth across the board. Sales, operating profits, and net income are all expanding at an excellent rate. This strong upward trend indicates high demand for its products and effective management in scaling the business profitably. The expansion of its asset base further supports this growth trajectory, positioning the company well for future performance and market share gains.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate15.6112.0312.4510.4317.32
Operating Profit Growth Rate-6.79-13.445.058.289.93
Earnings Per Share (EPS) Growth10.42-17.5138.8115.6714.71
Asset Growth Rate7.2714.55-1.138.2625.51
Net Income Growth Rate9.02-17.5338.7812.7514.78
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 8.40

The company demonstrates a strong financial profile from a shareholder's perspective, with excellent earnings and book value per share. It has also been generous with dividend payments. However, a significant amount of money is being spent on capital expenditures. While these investments are crucial for future growth, they represent a large cash outflow in the present, which is a key factor to note in its financial strategy.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
ExcellentDividend Per Share (DPS)Excellent
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)8447.5264.6473.2884.48
Cash Earnings Per Share (Cash EPS)98.5957.5276.0885.1298.32
Book Value Per Share384271.04285.36303.2362.16
Dividend Per Share (DPS)6.126.8850.32280
Capital Expenditures (CapEx)131173139317360
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's profitability is outstanding. It is highly effective at converting its revenue into profit at every level, from the gross profit on products sold to the final net income. Furthermore, it generates excellent returns on the money invested by both shareholders and lenders. This all-around strength in profitability is a key indicator of superior operational efficiency, strong market positioning, and effective management.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin24.1818.0924.6424.222.41
Return on Capital Employed (ROCE)2923323232
Return on Equity (ROE)21.8417.3622.8824.2723.33
Return on Assets (ROA)23.3317.6325.8725.8822.66
Operating Margin27.9321.5927.8527.325.58
Net Margin21.3415.7119.3919.7919.37
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

The company's performance in managing its assets and operations to generate revenue shows significant room for improvement. It appears to be slow in selling its inventory and collecting payments from its customers. Furthermore, the revenue generated from its fixed assets and overall capital is low. This suggests that while the company is profitable, its operational processes may not be as streamlined or effective as they could be, which can tie up cash and hinder overall performance.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
WeakReceivables Turnover RatioWeak
PoorDays Sales in Inventory RatioPoor
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.212.52.852.642.92
Inventory Turnover Ratio3.253.813.864.074.59
Receivables Turnover Ratio3.83.63.653.833.59
Days Sales in Inventory Ratio112.3195.894.5689.6879.52
Receivable Days96.05101.3910095.3101.67
Capital Turnover Ratio1.021.091.171.211.19
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 7.60

The company's position here is mixed. On one hand, its ability to cover interest payments on its debt is exceptionally strong, which is a direct benefit of its low-debt policy and removes any concern in this area. On the other hand, the earnings available to cover dividend payments to shareholders appear thin. This suggests that recent dividend payouts might be high relative to the profits being earned.

ExcellentInterest Coverage RatioExcellent
WeakEquity Dividend Coverage RatioWeak
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio91.9125.17160.1457.6287.12
Equity Dividend Coverage Ratio9.096.671.272.63
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's long-term financial stability is exceptionally strong. It operates with virtually no debt, financing its operations almost entirely through its own funds and profits. This extremely low reliance on borrowing means there is minimal risk of the company being unable to meet its long-term obligations. This conservative financial structure provides a very solid foundation for sustainable growth and resilience against economic downturns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.010.010.010.010.01
Debt to Equity Ratio0.010.010.010.010.01
Equity Ratio0.990.990.990.990.99
Debt To Asset Ratio0.010.010.010.010.01
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 7.44

The company's ability to cover its short-term bills is generally good. It holds enough easily accessible assets, even excluding inventory, to meet its immediate financial obligations, which is a positive sign of stability. However, its cash reserves are relatively low compared to its short-term liabilities. This suggests that while the company is not in immediate danger, it relies more on converting other assets like receivables into cash rather than having a large cash buffer on hand to pay its bills.

GoodCurrent RatiosGood
ExcellentQuick RatiosExcellent
WeakCash RatiosWeak
AverageOperating Cash Flow RatiosAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio3.082.022.642.342.18
Quick Ratio1.961.321.741.491.58
Cash Ratio0.30.290.140.160.07
Operating Cash Flow Ratio0.790.680.851.080.33
01.

Current Ratios

02.

Quick Ratios

03.

Cash Ratios

04.

Operating Cash Flow Ratios

Peer Comparison With 16 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
2J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
3Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
4Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
5Granules India Ltd7.7332.77Highly Overvalued1185.0016.17595.00
6Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
7Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
8Syngene International Ltd7.4456.08Overvalued918.007.55317.00
9Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
10ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
11Ipca Laboratories Ltd6.3335.26Neutral1979.0044.641184.00
12Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
13Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
14Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
15Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
16Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
Management Assessment Summary
GreenStrong Management

Management effectiveness is rated as strong, evidenced by outstanding capital efficiency, robust growth, and prudent financial stewardship. The company demonstrates excellent profitability with a ROCE of 32% and a stable ROE around 25%. Financial performance is marked by accelerating sales and strong profit growth, particularly over the last three years. The balance sheet is virtually debt-free, reflecting a conservative approach to leverage. High and stable promoter ownership, coupled with increasing DII interest, indicates strong confidence in the company's long-term strategy and execution. While the working capital cycle is long, the overall financial health and sustained performance metrics point to highly effective management.

Category Metric Value Assessment
PROS ROCE 32% Excellent capital efficiency
Debt/Equity Ratio 0.01 Negligible financial risk
3-Year Profit Growth CAGR 21% Strong earnings momentum
Promoter Holding 66.22% High promoter conviction
CONS Cash Conversion Cycle 233 days Inefficient working capital
Inventory Days 283 days High capital tied in inventory
ExcellentFinancial Performance & GrowthExcellent
ExcellentCapital Efficiency & ReturnsExcellent
ExcellentFinancial Health & PrudenceExcellent
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
GreenStrong Risk

The overall risk profile is low. The company's primary defense against risk is its fortress-like balance sheet, which is virtually debt-free, minimizing financial and solvency risks. Cash flow generation is strong, and accounting practices appear conservative with no major red flags. The main identifiable risk lies in working capital management, specifically the high levels of inventory and receivables, leading to a long cash conversion cycle. While this ties up capital and presents potential obsolescence or credit risk, the trend in the cash conversion cycle is improving. Given the company's high profitability and strong financial health, it is well-positioned to manage and absorb the potential impacts of this operational risk.

ExcellentFinancial Leverage RiskExcellent
GoodAccounting QualityGood
WeakWorking Capital RiskWeak
01.

Financial Leverage Risk

02.

Accounting Quality

03.

Working Capital Risk

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 103070.31Bullish
  3. SMA 203073.91Bearish
  4. SMA 503083.54Bearish
  5. EMA 103068.38Bullish
  6. EMA 203070.76Bullish
  7. EMA 503066.65Bullish
  8. DEMA 103065.11Bullish
  9. DEMA 203068.14Bullish
  10. DEMA 503080.37Bearish
  11. TEMA 103063.79Bullish
  12. TEMA 203064.48Bullish
  13. TEMA 503080.12Bearish
  14. MACD-2.16Bearish
  15. ADX11.72Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI50.04Neutral
  3. CCI-38.88Neutral
  4. ROC 9-0.46Bearish
  5. ROC 140.37Bullish
  6. ROC 250.84Bullish
  7. Stoch K28.86Neutral
  8. Stoch D22.82Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3094.40Neutral
  3. BB Middle3073.91Neutral
  4. BB Lower3053.43Neutral
  5. ATR24.02Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI58.51Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 103071.93Bearish
  3. SMA 203067.47Bullish
  4. SMA 503044.99Bullish
  5. EMA 103071.47Bearish
  6. EMA 203071.27Bullish
  7. EMA 503058.22Bullish
  8. DEMA 103069.25Bullish
  9. DEMA 203077.34Bearish
  10. DEMA 503074.54Bearish
  11. TEMA 103068.14Bullish
  12. TEMA 203068.57Bullish
  13. TEMA 503081.36Bearish
  14. MACD3.19Bearish
  15. ADX22.15Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI50.91Neutral
  3. CCI-1.51Neutral
  4. ROC 9-0.29Bearish
  5. ROC 141.24Bullish
  6. ROC 25-2.25Bearish
  7. Stoch K45.20Neutral
  8. Stoch D46.91Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3096.70Neutral
  3. BB Middle3067.46Neutral
  4. BB Lower3038.23Neutral
  5. ATR34.30Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI56.14Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 103065.66Bullish
  3. SMA 203068.41Bullish
  4. SMA 503068.13Bullish
  5. EMA 103071.74Bearish
  6. EMA 203062.61Bullish
  7. EMA 503043.71Bullish
  8. DEMA 103077.55Bearish
  9. DEMA 203078.13Bearish
  10. DEMA 503085.43Bearish
  11. TEMA 103070.33Bullish
  12. TEMA 203086.09Bearish
  13. TEMA 50N/AN/A
  14. MACD11.79Bearish
  15. ADX25.58Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.13Neutral
  3. CCI-3.64Neutral
  4. ROC 90.70Bullish
  5. ROC 14-0.19Bearish
  6. ROC 256.21Bullish
  7. Stoch K35.02Neutral
  8. Stoch D41.48Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3161.93Neutral
  3. BB Middle3068.41Neutral
  4. BB Lower2974.90Neutral
  5. ATR57.15Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI52.24Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 103059.89Bullish
  3. SMA 203035.20Bullish
  4. SMA 502970.85Bullish
  5. SMA 1002930.50Bullish
  6. SMA 2002750.46Bullish
  7. EMA 103062.76Bullish
  8. EMA 203047.29Bullish
  9. EMA 502998.46Bullish
  10. EMA 1002924.95Bullish
  11. EMA 2002829.34Bullish
  12. DEMA 103081.56Bearish
  13. DEMA 203075.63Bearish
  14. DEMA 503076.71Bearish
  15. DEMA 1003054.32Bullish
  16. DEMA 2002969.43Bullish
  17. TEMA 103092.09Bearish
  18. TEMA 203070.36Bullish
  19. TEMA 503081.98Bearish
  20. TEMA 1003092.92Bearish
  21. TEMA 2003024.92Bullish
  22. MACD21.16Bullish
  23. ADX15.31Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.99Neutral
  3. CCI35.00Neutral
  4. ROC 144.94Bullish
  5. ROC 25-1.59Bearish
  6. Stoch K69.14Neutral
  7. Stoch D69.62Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3188.17Neutral
  3. BB Middle3035.20Neutral
  4. BB Lower2882.23Neutral
  5. ATR93.96Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI64.04Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 202928.99Bullish
  3. SMA 502734.43Bullish
  4. EMA 202916.59Bullish
  5. EMA 502794.67Bullish
  6. DEMA 203033.49Bullish
  7. DEMA 502937.23Bullish
  8. TEMA 203065.46Bullish
  9. TEMA 502961.31Bullish
  10. MACD88.48Bullish
  11. ADX32.26Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI59.72Neutral
  3. CCI139.48Overbought
  4. ROC 144.65Bullish
  5. ROC 2518.93Bullish
  6. Stoch K51.03Neutral
  7. Stoch D54.16Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3171.43Neutral
  3. BB Middle2928.99Neutral
  4. BB Lower2686.55Neutral
  5. ATR190.80High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI60.53Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 62850.23Bullish
  3. SMA 122694.74Bullish
  4. SMA 242741.84Bullish
  5. EMA 62824.50Bullish
  6. EMA 122751.26Bullish
  7. EMA 242606.71Bullish
  8. DEMA 62905.55Bullish
  9. DEMA 122864.71Bullish
  10. DEMA 242923.26Bullish
  11. TEMA 62927.53Bullish
  12. TEMA 122864.50Bullish
  13. TEMA 242878.09Bullish
  14. MACD398.75Bearish
  15. ADX38.65Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI61.67Neutral
  3. CCI98.14Neutral
  4. ROC 2532.20Bullish
  5. ROC 50142.63Bullish
  6. Stoch K46.73Neutral
  7. Stoch D59.58Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper3112.91Neutral
  3. BB Middle2718.83Neutral
  4. BB Lower2324.76Neutral
  5. ATR345.79High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI59.88Neutral